DJIA 17,039.49 60.36 0.36%
NASDAQ 4,532.10 5.62 0.12%
S&P 500 1,992.37 5.86 0.29%
market minute promo

AVANIR PHARMACEUTICALS (NASDAQ: AVNR)

5.66 -0.07 (-1.22%)

REAL-TIME: Last trade at

Extended Hours: $5.66 $0.00 (-0.02%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

AVNR $5.66 -1.22%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.74
Previous Close $5.73
Daily Range $5.62 - $5.78
52-Week Range $2.62 - $6.00
Market Cap $972.6M
P/E Ratio -12.19
Dividend (Yield) $0.00 (0.0%)
Volume 911,718
Average Daily Volume 1,790,254
Current FY EPS -$0.27

Sector

Healthcare

Industry

Drugs

AVANIR PHARMACEUTICALS (AVNR) Description

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. Website: http://www.avanir.com/

News & Commentary

3 Biotech Stocks with Catalysts Incoming: Spectrum, Orexigen, and Avanir

For companies involved in the development of drugs, a PDUFA decision will meaningfully impact their stocks. With this in mind, there are several PDUFA decisions in upcoming months to watch for.

An Update On A Couple Of Small Biotech Plays

Biodel Q3 Loss Narrower than Expected, Gives Pipeline Update - Analyst Blog

Avanir's Q3 Loss in Line, Revenues Up on High Nuedexta Demand - Analyst Blog

Avanir Pharmaceuticals' (AVNR) CEO Keith Katkin on Q3 2014 Results - Earnings Call Transcript

Avanir Pharmaceuticals (AVNR) Q3 2014 Results - Earnings Call Webcast

Insider Trading Alert - HERO, AVNR And CNMD Traded By Insiders

Avanir to Conduct Phase II Study on AVP-786 for Depression - Analyst Blog

Avanir Pharmaceuticals Announces FDA Acceptance Of IND For AVP-786, Used For Adjunctive Treatment Of

Avanir Pharmaceuticals Announces FDA Acceptance Of IND For AVP-786, Used For Adjunctive Treatment Of Major Depressive Disorder

3 Biotech Stocks Under $10 to Trade for Breakouts

Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting - Analyst Blog

See More AVNR News...

AVNR's Top Competitors

AVNR $5.66 (-1.22%)
Current stock: AVNR
JNJ $104.19 (0.95%)
Current stock: JNJ
NVS $88.95 (0.40%)
Current stock: NVS
RHHBY $36.44 (-0.02%)
Current stock: RHHBY